Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol

Blood

Volumn 114, Issue 18, 2009, Pages 3764-3768

  Van Der Linden, Marieke H ^a   Valsecchi, Maria Grazia ^b   De Lorenzo, Paola ^b   Möricke, Anja ^c   Janka, Gritta ^d   Leblanc, Thierry M ^e   Felice, Maria ^f   Biondi, Andrea ^b   Campbell, Myriam ^g   Hann, Ian ^h   Rubnitz, Jeffrey E ⁱ   Stary, Jan ^j   Szczepanski, Tomasz ^k   Vora, Ajay ^l   Ferster, Alina ^m   Hovi, Liisa ⁿ   Silverman, Lewis B ^o   Pieters, Rob ^a,p  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e SAINT LOUIS HOSPITAL   (France)

^f HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^g HOSPITAL ROBERTO DEL RÍO   (Chile)

^h GREAT ORMOND STREET HOSPITAL   (United Kingdom)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^k MEDICAL UNIVERSITY OF SILESIA   (Poland)

^l SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^m HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

ⁿ UNIVERSITY OF HELSINKI   (Finland)

^o DANA FARBER CANCER INSTITUTE   (United States)

^p DCOG Dutch Childhood Oncology Group   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE; ANTINEOPLASTIC AGENT; MEMBRANE METALLOENDOPEPTIDASE; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; EVENT FREE SURVIVAL; FATALITY; FEMALE; GENE REARRANGEMENT; HUMAN; INCIDENCE; INFANT; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; MLL GENE; MULTIPLE CYCLE TREATMENT; ONCOGENE; PRIORITY JOURNAL; RARE DISEASE; TREATMENT OUTCOME; B LYMPHOCYTE; BLOOD; DISEASE FREE SURVIVAL; FOLLOW UP; GENETICS; MORTALITY; MULTICENTER STUDY; NEWBORN; RECURRENT DISEASE; REMISSION; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE REARRANGEMENT; HUMANS; INFANT, NEWBORN; LEUKOCYTE COUNT; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEPRILYSIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; SURVIVAL RATE;

EID: 70449706226     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-204214     Document Type: Article

References (20)

1. Pieters R, Biology and treatment of infant leukemias. In: Pui CH, ed. Treatment of Acute Leukemias: New Directions for Clinical Research. Totowa, NJ: Humana Press; 2003:61-73.
2. Biondi A, Cimino G, Pieters R, Pui CH. Biological and therapeutic insights of infant leukemia. Blood. 2000;96(1):24-33.
3. Pieters R, den Boer ML, Durian M,et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia: implications for treatment of infants. Leukemia. 1998;12(9):1344-1348.
4. Reiter A, Schrappe M, Ludwig W-D, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL BFM 86. Blood. 1994;84(9):3122-3133.
5. Silverman LB, McLean TW, Gelber RD, et al. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana Farber Cancer Institute Consortium. Cancer. 1997;80(12):2285-2295.
6. Biondi A, Rizzari C, Valsecchi MG, et al. Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. Haematologica. 2006;91(4):534-537.
7. Dordelmann M, Reiter A, Borkhardt A, et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood. 1999;94(4):1209-1217.
8. Ferster A, Bertrand Y, Benoit Y, et al. Improved survival for acute lymphoblastic leukemia in infancy: the experience of EORTC-Childhood Leukemia Cooperative Group. Br J Haematol. 1994;86(2):284-290.
9. Hilden JM, Dinndorf PA, Meerbaum SO, et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood. 2006;108(2):441-451.
10. Reaman GH, Sposto R, Sensel MG, et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol. 1999;17(2):445-455.
11. Chessells JM, Harrison CJ, Watson SL, et al. Treatment of infants with lymphoblastic leukemia: results of the UK Infant Protocols 1987-1999. Br J Haematol. 2002;117(2):306-314.
12. Frankel LS, Ochs J, Shuster JJ, et al. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493). J Pediatr Hematol Oncol. 1997;19(1):35-42.
13. Lauer SJ, Camitta BM, Leventhal BG, et al. Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: a Pediatric Oncology Group pilot study. J Pediatr Hematol Oncol. 1998;20(3):229-233.
14. Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370(9583):240-250.
15. Bresters D, Reus ACW, Veerman AJP, et al. Congenital leukemia: the Dutch experience and review of the literature. Br J Haematol. 2002;117(3):513-524.
16. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-178.
17. Creutzig U, Zimmermann M, Ritter J, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia. 2005;19(12):2030-2042.
18. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141-1154.
19. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A. 1997;94(25):13950-13954.
20. Stam RW, den Boer ML, Pieters R. Toward targeted therapy for infant acute lymphoblastic leukaemia. Br J Haematol. 2006;132(5):539-551.